| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 113.5 | 89.8 |
| Profit before tax | 562.8 | 32.4 |
| Net income | 563.5 | 32.9 |
| EPS (diluted, $ a share) | $11.47 | $0.69 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +1614.8% |
|---|---|
| Revenue, year on year | +26.3% |
10-Q filed with the SEC, NYSE: NHI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
National Health Investors Inc: key numbers
- Share price
- $59.98Close, Nov 17
- Market cap
- $2.95B
- Shares outstanding
- 49.11MLatest SEC cover page
- Sector
- Real Estate & Construction
- Industry
- Real Estate Investment TrustsSIC 6798
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from National Health Investors Inc
All →National Health Investors Executive Compensation
National Health Investors entered into new indemnification agreements with its directors and executive officers. The agreements obligate the company to indemnify these individuals to the maximum extent permitted by Maryland law for expenses and liabilities incurred due to their status as company officials, provided they acted in good faith. This is a standard corporate governance and compensatory arrangement to protect leadership from personal liability.
National Health Investors Investor Presentation
National Health Investors (NHI) furnished a formal investor presentation titled 'Q3 2026 Business Update' on November 9, 2026. The presentation provides a strategic and operational update on the company's senior housing and medical facility real estate portfolio. The filing was made under Item 7.01 to provide transparency to investors regarding current business trends.
National Health Investors Business Update
National Health Investors (NHI) furnished its supplemental information package for the third quarter ended September 30, 2026. The document provides operational metrics and portfolio overviews, including senior housing operating portfolio performance and lease coverage data. This filing serves as a Regulation FD disclosure of non-GAAP and operational data rather than a formal GAAP earnings release.
National Health Investors Financial Results
National Health Investors reported Q3 2026 financial results, highlighted by a significant increase in net income to $11.47 per diluted share, primarily driven by a $541.6 million gain from the sale of the NHC leased portfolio. The company has closed over $395 million in investments year-to-date and expects to complete additional acquisitions before year-end to drive SHOP segment growth.
- Term
- Q3 2026
“SHOP and private-pay senior housing remain central to our long-term growth strategy, and we have invested in our executive management team to strengthen operating execution and improve portfolio performance.”
Eric Mendelsohn, NHI’s President and CEO
“We have closed more than $395 million in investments year-to-date and expect to complete significant additional investments before year-end, with ample capital available to fund our current pipeline.”
Eric Mendelsohn, NHI’s President and CEO